サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1392719

炎症性腸疾患治療の世界市場レポート 2024年

Inflammatory Bowel Disease Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
炎症性腸疾患治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

炎症性腸疾患治療市場規模は近年力強く成長しています。2023年の234億9,000万米ドルから2024年には255億6,000万米ドルに、CAGR8.8％で拡大します。過去数年間における増加は、炎症性腸疾患の有病率の上昇、生物学的製剤や免疫調節薬に対するニーズの高まり、治療法の選択肢の進歩、高齢者人口の拡大、疾患に対する意識の高まりが原因であると考えられます。

2023年の炎症性腸疾患治療市場で最大の地域は北米でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。炎症性腸疾患治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 炎症性腸疾患治療市場の特徴

第3章 炎症性腸疾患治療市場の動向と戦略

第4章 炎症性腸疾患治療市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の炎症性腸疾患治療市場の規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033F

第6章 炎症性腸疾患治療市場セグメンテーション

  • 世界の炎症性腸疾患治療市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • クローン病
  • 潰瘍性大腸炎
  • 世界の炎症性腸疾患治療市場、薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • アミノサリチル酸塩
  • コルチコステロイド
  • TNF阻害剤
  • IL阻害剤
  • 抗インテグリン
  • JAK阻害剤
  • 他の薬物クラス
  • 世界の炎症性腸疾患治療市場、投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • オーラル
  • 注射可能
  • 世界の炎症性腸疾患治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 炎症性腸疾患治療市場の地域および国分析

  • 世界の炎症性腸疾患治療市場、地域別、実績および予測、2018年から2023年、2023年から2028年まで、2033年まで
  • 世界の炎症性腸疾患治療市場、国別、実績および予測、2018年から2023年、2023年から2028年まで、2033年まで

第8章 アジア太平洋の炎症性腸疾患治療市場

  • 概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国の炎症性腸疾患治療市場

第10章 インドの炎症性腸疾患治療市場

第11章 日本の炎症性腸疾患治療市場

第12章 オーストラリアの炎症性腸疾患治療市場

第13章 インドネシアの炎症性腸疾患治療市場

第14章 韓国の炎症性腸疾患治療市場

第15章 西欧の炎症性腸疾患治療市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国の炎症性腸疾患治療市場

第17章 ドイツの炎症性腸疾患治療市場

第18章 フランスの炎症性腸疾患治療市場

第19章 イタリアの炎症性腸疾患治療市場

第20章 スペインの炎症性腸疾患治療市場

第21章 東欧の炎症性腸疾患治療市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアの炎症性腸疾患治療市場

第23章 北米の炎症性腸疾患治療市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国の炎症性腸疾患治療市場

第25章 カナダの炎症性腸疾患治療市場

第26章 南米の炎症性腸疾患治療市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルの炎症性腸疾患治療市場

第28章 中東の炎症性腸疾患治療市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカの炎症性腸疾患治療市場

  • 概要
  • タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 薬剤クラス別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 炎症性腸疾患治療市場の競合情勢と企業プロファイル

  • 炎症性腸疾患治療市場の競合情勢
  • 炎症性腸疾患治療市場の企業プロファイル
    • AbbVie Inc.
    • Biogen Inc.
    • Johnson & Johnson
    • Amgen Inc.
    • Union Chimique Belge S. A.

第31章 世界の炎症性腸疾患治療市場の競合ベンチマーキング

第32章 世界の炎症性腸疾患治療市の競合ダッシュボード

第33章 炎症性腸疾患治療市場における主要な合併と買収

第34章 炎症性腸疾患治療市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10407

“Inflammatory Bowel Disease Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inflammatory bowel disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inflammatory bowel disease treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The inflammatory bowel disease treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Drug Class: Aminosalicylates; Corticosteroids; TNF inhibitors; IL inhibitors; Anti-integrin; JAK inhibitors; Other Drug Classes
  • 2) By Type: Crohn's Disease; Ulcerative Colitis
  • 3) By Route of Administration: Oral; Injectable
  • 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
  • Companies Mentioned: AbbVie Inc.; Biogen Inc.; Johnson & Johnson; Amgen Inc.; Union Chimique Belge S. A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Treatment for inflammatory bowel disease involves the use of anti-inflammatory medications commonly employed for mild to moderate cases of ulcerative colitis. Aminosalicylates, including mesalamine (Delzicol, Rowasa, among others), balsalazide (Colazal), and olsalazine, serve as anti-inflammatories, with Dipentum being one of them.

The primary drug categories in the treatment of inflammatory bowel disease encompass aminosalicylates, corticosteroids, TNF inhibitors, IL inhibitors, anti-integrin, JAK inhibitors, and other options. Aminosalicylates, a specific class of drugs, are utilized to manage and prevent flare-ups in ulcerative colitis and Crohn's disease. The mechanism of action of aminosalicylates involves inhibiting the production of cyclo-oxygenase, prostaglandin, thromboxane synthetase, platelet-activating factor synthetase, and interleukin-1 by macrophages. Both orally and via injection, treatments for inflammatory bowel disease are administered for Crohn's disease and ulcerative colitis. These medications are available through hospital pharmacies, retail pharmacies, and online pharmacies.

The inflammatory bowel disease treatment market research report is one of a series of new reports from The Business Research Company that provides inflammatory bowel disease treatment market statistics, including inflammatory bowel disease treatment industry global market size, regional shares, competitors with an inflammatory bowel disease treatment market share, detailed inflammatory bowel disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the inflammatory bowel disease treatment industry. This inflammatory bowel disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The inflammatory bowel disease treatment market size has grown strongly in recent years. It will grow from $23. 49 billion in 2023 to $25. 56 billion in 2024 at a compound annual growth rate (CAGR) of 8. 8%. The rise during the historical period can be ascribed to a heightened prevalence of inflammatory bowel disease, a growing need for biologics and immunomodulators, advancements in treatment choices, an expanding geriatric population, and an increased awareness regarding the disease.

The inflammatory bowel disease treatment market size is expected to see strong growth in the next few years. It will grow to $36. 63 billion in 2028 at a compound annual growth rate (CAGR) of 9. 4%. The expansion projected for the forecast period can be linked to a surge in investment in research and development activities, a rising demand for biosimilars, an increasing incidence of inflammatory bowel disease in emerging markets, a growing preference for personalized medicine, and the integration of precision medicine in IBD treatment. Key trends expected in the forecast period involve a rise in product launches and approvals, the implementation of personalized dosing and treatment plans in IBD management, the utilization of telemedicine for remote monitoring of IBD patients, exploration of microbiome-based therapies for IBD, and the adoption of value-based care models in IBD treatment.

The significant increase in the prevalence of Crohn's disease and ulcerative colitis is a key driver for the growth of the market for inflammatory bowel disease treatment. Crohn's disease and ulcerative colitis, categorized as inflammatory bowel diseases (IBD), involve inflammation and ulcers in the digestive tracts. The growing incidence of these diseases is expected to elevate the demand for treatments that aim to reduce bowel inflammation and prevent medical complications. A March 2022 research publication from the United States National Library of Medicine indicates that approximately 1. 6 million Americans presently suffer from inflammatory bowel disease, with around 70,000 new cases diagnosed annually in the USA. Consequently, the increasing prevalence of Crohn's disease and ulcerative colitis is anticipated to propel the growth of the inflammatory bowel disease treatment market.

The rise in the geriatric population is forecasted to drive the growth of the inflammatory bowel disease treatment market in the future. The geriatric population, comprising individuals aged 65 and older, exhibits a higher susceptibility to inflammatory bowel diseases, resulting in an increased demand for treatments and therapies. This demographic shift is expected to contribute to the expansion of the inflammatory bowel disease treatment market. A report from the World Health Organization (WHO) in October 2022 highlights that by the year 2030, one in six people globally is expected to be 60 or older, and by 2050, there will be an estimated 2. 1 billion people worldwide aged 60 or older. Thus, the growth of the geriatric population is a significant factor propelling the inflammatory bowel disease treatment market.

Technological advancement is a prominent trend gaining traction in the inflammatory bowel disease treatment market. Key market players are actively adopting technologies like artificial intelligence (AI) in drug discovery processes and introducing advanced treatments for inflammatory bowel diseases. Collaboration between major players and technology firms is a prevalent strategy to leverage their respective strengths and technologies for developing new treatments and enhancing their market position. For example, in May 2021, CytoReason, an Israeli technology start-up specializing in a computational model of the human body, partnered with Ferring Pharmaceuticals, a Switzerland-based multinational pharmaceutical company, to utilize artificial intelligence technology in the drug discovery process for new inflammatory bowel disease treatments. The collaboration combines Ferring's medical expertise with CytoReason's AI technology to create cell-centered disease models, providing critical insights into cellular-level functioning and disease treatment.

Major companies in the inflammatory bowel disease treatment market are focusing on the development of innovative products targeting larger customer bases and increasing revenue. Treatments for moderate to severe active ulcerative colitis, involving medications and sometimes surgical interventions, are a key area of innovation. In October 2023, Eli Lilly and Company, a US-based pharmaceutical company, received U. S. Food and Drug Administration (FDA) approval for Omvoh (mirikizumab-mrkz), the first interleukin-23p19 (IL-23p19) antagonist designed to treat adults with moderately to severely active ulcerative colitis (UC). Omvoh targets the IL-23 pathway, effectively blocking inflammation associated with UC. The treatment regimen involves initial infusions followed by subcutaneous self-injections during the maintenance phase.

In March 2022, Pfizer, Inc., a U. S. -based pharmaceutical and biotechnology company, acquired Arena Pharmaceuticals, Inc., for $6. 7 billion. Through this acquisition, Pfizer aims to enhance its research capabilities in the Inflammation and Immunology therapeutic area, develop therapies for immuno-inflammatory diseases, and continue the clinical development of existing drug candidates. Arena Pharmaceuticals, Inc., is a U. S. -based biopharmaceutical company specializing in the development of novel treatments for various immuno-inflammatory conditions.

Major companies operating in the in the inflammatory bowel disease treatment market report are AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Union Chimique Belge S. A., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic - Gastroenterology West P. C., Ebony 60 Inc., Salix Pharmaceuticals Inc., Shire plc, Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

North America was the largest region in the inflammatory bowel disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the inflammatory bowel disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The inflammatory bowel disease treatment market includes revenues earned by entities by reducing the inflammation that triggers the signs and symptoms. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Inflammatory Bowel Disease Treatment Market Characteristics

3. Inflammatory Bowel Disease Treatment Market Trends And Strategies

4. Inflammatory Bowel Disease Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Inflammatory Bowel Disease Treatment Market Size and Growth

  • 5.1. Global Inflammatory Bowel Disease Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Inflammatory Bowel Disease Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Inflammatory Bowel Disease Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Inflammatory Bowel Disease Treatment Market Segmentation

  • 6.1. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Crohn's Disease
  • Ulcerative Colitis
  • 6.2. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Aminosalicylates
  • Corticosteroids
  • TNF inhibitors
  • IL inhibitors
  • Anti-integrin
  • JAK inhibitors
  • Other Drug Classes
  • 6.3. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injectable
  • 6. 4. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Inflammatory Bowel Disease Treatment Market Regional And Country Analysis

  • 7.1. Global Inflammatory Bowel Disease Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Inflammatory Bowel Disease Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Inflammatory Bowel Disease Treatment Market

  • 8.1. Asia-Pacific Inflammatory Bowel Disease Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Inflammatory Bowel Disease Treatment Market

  • 9.1. China Inflammatory Bowel Disease Treatment Market Overview
  • 9.2. China Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Inflammatory Bowel Disease Treatment Market

  • 10.1. India Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Inflammatory Bowel Disease Treatment Market

  • 11.1. Japan Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Inflammatory Bowel Disease Treatment Market

  • 12.1. Australia Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Inflammatory Bowel Disease Treatment Market

  • 13.1. Indonesia Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Inflammatory Bowel Disease Treatment Market

  • 14.1. South Korea Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Inflammatory Bowel Disease Treatment Market

  • 15.1. Western Europe Inflammatory Bowel Disease Treatment Market Overview
  • 15.2. Western Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Inflammatory Bowel Disease Treatment Market

  • 16.1. UK Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Inflammatory Bowel Disease Treatment Market

  • 17.1. Germany Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Inflammatory Bowel Disease Treatment Market

  • 18. 5. France Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Inflammatory Bowel Disease Treatment Market

  • 19. 9. Italy Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Inflammatory Bowel Disease Treatment Market

  • 20.13. Spain Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Inflammatory Bowel Disease Treatment Market

  • 21.1. Eastern Europe Inflammatory Bowel Disease Treatment Market Overview
  • 21.2. Eastern Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Inflammatory Bowel Disease Treatment Market

  • 22.1. Russia Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Inflammatory Bowel Disease Treatment Market

  • 23.1. North America Inflammatory Bowel Disease Treatment Market Overview
  • 23.2. North America Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Inflammatory Bowel Disease Treatment Market

  • 24.1. USA Inflammatory Bowel Disease Treatment Market Overview
  • 24.2. USA Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Inflammatory Bowel Disease Treatment Market

  • 25.1. Canada Inflammatory Bowel Disease Treatment Market Overview
  • 25.2. Canada Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Inflammatory Bowel Disease Treatment Market

  • 26.1. South America Inflammatory Bowel Disease Treatment Market Overview
  • 26.2. South America Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Inflammatory Bowel Disease Treatment Market

  • 27.1. Brazil Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Inflammatory Bowel Disease Treatment Market

  • 28.1. Middle East Inflammatory Bowel Disease Treatment Market Overview
  • 28.2. Middle East Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Inflammatory Bowel Disease Treatment Market

  • 29.1. Africa Inflammatory Bowel Disease Treatment Market Overview
  • 29.2. Africa Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Inflammatory Bowel Disease Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Inflammatory Bowel Disease Treatment Market Competitive Landscape
  • 30.2. Inflammatory Bowel Disease Treatment Market Company Profiles
    • 30.2.1. AbbVie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. Biogen Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Johnson & Johnson
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. Amgen Inc.
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. Union Chimique Belge S. A.
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Inflammatory Bowel Disease Treatment Market Competitive Benchmarking

32. Global Inflammatory Bowel Disease Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Inflammatory Bowel Disease Treatment Market

34. Inflammatory Bowel Disease Treatment Market Future Outlook and Potential Analysis

  • 34.1 Inflammatory Bowel Disease Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Inflammatory Bowel Disease Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Inflammatory Bowel Disease Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer